Screening of shared molecular markers between cervical cancer and major depressive disorder and the mechanism of CRAT/CLIC4 regulating EMT in cervical cancer cells [0.03%]
宫颈癌和抑郁症共有的分子标记物筛选及CRAT/CLIC4在宫颈癌细胞中调控EMT的机制研究
Hua-Hua Zhang,Min Liu,Ya-Ni Chen et al.
Hua-Hua Zhang et al.
Background: Cervical cancer (CC) ranks among the most prevalent malignant neoplasms affecting women worldwide. Tumor recurrence, distant metastases, and chemotherapy resistance significantly hinder long-term clinical surv...
Systematic review and meta-analysis of lung metastases incidence in cervical cancer patients [0.03%]
宫颈癌患者肺转移发生率的系统评价和meta分析
Kimia Pakdaman,Amin Esmaeilnia Shirvani,Kasra Pakdaman et al.
Kimia Pakdaman et al.
Background: Cervical cancer (CC) is a common and aggressive malignancy in women. The lung is its most frequent site of distant metastasis, yet the incidence and risk factors remain underexplored. This study aimed to estim...
Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in ras wild-type metastatic colorectal cancer: a single-center exploratory randomized trial [0.03%]
西妥昔单抗-伊立替康再挑战治疗与瑞戈非尼治疗KRAS野生型转移性结直肠癌的疗效和安全性：一项单中心探索性随机试验
Hao Chen,Tao Jiang,Han Wang et al.
Hao Chen et al.
Background: Anti-epidermal growth factor receptor (EGFR) antibodies are widely used in the treatment of RAS wild-type metastatic colorectal cancer (mCRC) across various lines of therapy, including after disease progressio...
Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway [0.03%]
撤回 notice: 阿托伐醌通过调节PDGFRβ/NF-κB信号通路抑制结直肠癌转移
Bin Liu,Xin Zheng,Jiajun Li et al.
Bin Liu et al.
Incidence trends, mortality, and treatment-related toxicity in osteosarcoma, neuroblastoma, and acute lymphoblastic leukemia in Kazakhstan [0.03%]
哈萨克斯坦骨肉瘤、神经母细胞瘤和急性淋巴细胞白血病的发病率趋势、死亡率和治疗相关毒性
Gulnara Abdilova,Aigul Bazarbayeva,Gulnara Tashenova et al.
Gulnara Abdilova et al.
Background: Pediatric cancer survival has improved substantially worldwide; however, evolving incidence patterns and treatment-related toxicity continue to challenge health systems, particularly in transitioning settings....
Retraction Note: Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21 [0.03%]
撤回 notice:长链非编码rna BRE-AS1通过下调miR-21抑制三阴性乳腺癌细胞的增殖、迁移和侵袭并预测患者的生存率
Jianchao Gao,Sisi Wang,Zhisheng Zhang et al.
Jianchao Gao et al.
Anti-BNLF2b antibody for accurate diagnosis of nasopharyngeal carcinoma: a prospective comparative study [0.03%]
抗BNLF2b抗体用于鼻咽癌的精准诊断：一项前瞻性对比研究
Bixia Huang,Lu Yang,Xingxing Luo et al.
Bixia Huang et al.
Background: Nasopharyngeal carcinoma (NPC) is highly prevalent in Southern China and Southeast Asia and early detection significantly improves prognosis. Conventional Epstein-Barr virus (EBV) serological markers VCA-IgA a...
Exploratory clinical-CT machine learning characterization of CK7 expression in clear cell renal cell carcinoma [0.03%]
基于临床-CT的机器学习表征CK7在透明细胞肾细胞癌中的表达探究
Qiansen Lin,Gengyun Miao,Xi Jia et al.
Qiansen Lin et al.
Background: Cytokeratin 7 (CK7) expression in clear cell renal cell carcinoma (ccRCC) may reflect tumor phenotype and biological heterogeneity, but its clinical role remains exploratory. This study aimed to investigate as...
Real-world evidence for atezolizumab with bevacizumab for unresectable hepatocellular carcinoma: a multicentre UK Midlands cohort [0.03%]
阿特珠单抗与贝伐珠单抗治疗不可切除的肝细胞癌的真实世界证据：英国中部多中心队列研究
Richard Phillips,Harry Daniels,Marie Quinlan et al.
Richard Phillips et al.
Background: The IMbrave150 trial established atezolizumab plus bevacizumab (ATE/BEV) as first-line standard of care for unresectable hepatocellular carcinoma (HCC), demonstrating superior overall survival (OS) and progres...
Diagnostic delay as health system navigation: a mixed-methods study of childhood cancer in Burkina Faso [0.03%]
Burkina Faso儿童癌症诊断延误的混合方法研究：作为卫生系统导航的一部分
Akiko Ida,Sonia Douamba Kaboret,Gabrielle Chantal Bouda et al.
Akiko Ida et al.
Background: Diagnostic delay is a major contributor to childhood cancer mortality in low- and middle-income countries (LMICs). Existing studies identify determinants of delay but provide limited insight into how delays ac...